RxDoctor Payments Data

Laura Lester, MD

Family Medicine · Fayetteville, ARNPI 1568801447

Payments from drug & device makers

$3,115in general payments, 2019–2025

Across 201 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$645
  • AbbVie$635
  • Lilly USA, LLC$261
  • Corium, LLC$205
  • AstraZeneca$164
  • Supernus Pharmaceuticals, Inc.$132
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$3,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,115 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$84,471
Medicare patients
248
Services billed
2,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate26$31,086
OzempicSemaglutide27$26,738
JardianceEmpagliflozin17$20,426
CaplytaLumateperone Tosylate12$19,618
EliquisApixaban26$17,949
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$12,438
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$8,048
Tresiba Flextouch U-200Insulin Degludec11$7,528
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen137$3,556
Albuterol Sulfate HfaAlbuterol Sulfate108$2,814
Omeprazole199$2,757
Atorvastatin Calcium256$2,260
Gabapentin154$2,191
Levothyroxine Sodium207$1,769
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$61$31,08626 claims
Novo NordiskOzempic$67$26,73827 claims
GSKTrelegy Ellipta, Anoro Ellipta$61$20,48641 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$27$19,61812 claims
PfizerEliquis$645$17,94926 claims
AbbVieSynthroid$635$75425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →